XORTX Therapeutics (XRTX) Change in Cash (2020 - 2026)
XORTX Therapeutics (XRTX) posted Change in Cash of -$614239.0 for Q1 2026, down 86.47% on a QoQ basis from -$329401.0 in Q4 2025, and down 6.19% year-over-year from -$654798.6 in Q1 2025.
XORTX Therapeutics (XRTX) Change in Cash (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Change in Cash history runs 7 years deep, the most recent figure standing at -$614239.0 for Q1 2026.
- Quarterly Change in Cash fell 6.19% year-over-year to -$614239.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 million (up 15.22% YoY) and the FY2025 annual result came in at -$1.6 million, down 65.21% from the prior year.
- Change in Cash was -$614239.0 for Q1 2026 at XORTX Therapeutics, down from -$329401.0 in the prior quarter.
- Across five years, Change in Cash topped out at $7.0 million in Q2 2022 and bottomed at -$8.4 million in Q4 2022.
- A 5-year average of -$787224.4 and a median of -$756968.0 in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash soared 1064.04% — and 2025, when it tumbled 290.51%.
- XORTX Therapeutics' Change in Cash stood at -$8.4 million in 2022, then surged by 80.72% to -$1.6 million in 2023, then jumped by 110.66% to $172902.0 in 2024, then tumbled by 290.51% to -$329401.0 in 2025, then sank by 86.47% to -$614239.0 in 2026.
- Business Quant data shows XRTX's Change in Cash at -$614239.0 in Q1 2026, -$329401.0 in Q4 2025, and $130438.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | -614,239.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -614,239.00 |
| Dec 31, 2025 | -329,401.00 |
| Sep 30, 2025 | 130,438.00 |
| Jun 30, 2025 | -831,761.00 |
| Mar 31, 2025 | -578,411.00 |
| Dec 31, 2024 | 172,902.00 |
| Sep 30, 2024 | -777,725.00 |
| Jun 30, 2024 | -756,968.00 |
| Mar 31, 2024 | 387,775.00 |
| Dec 31, 2023 | -1.62 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Mar 31, 2023 | -2.53 Mn |
| Dec 31, 2022 | -8.41 Mn |
| Sep 30, 2022 | 829,424.68 |
| Jun 30, 2022 | 7.02 Mn |
| Mar 31, 2022 | -2.64 Mn |
| Dec 31, 2021 | 10.99 Mn |
| Sep 30, 2021 | -119,881.93 |
| Jun 30, 2021 | -728,294.73 |